NZ503484A - Optionally benzo fused thieno[2,3-b]benzoxazepine, thieno[2,3-b]benzodiazepine or thieno[2,3-b]benzothiaxazepine derivatives - Google Patents

Optionally benzo fused thieno[2,3-b]benzoxazepine, thieno[2,3-b]benzodiazepine or thieno[2,3-b]benzothiaxazepine derivatives

Info

Publication number
NZ503484A
NZ503484A NZ503484A NZ50348498A NZ503484A NZ 503484 A NZ503484 A NZ 503484A NZ 503484 A NZ503484 A NZ 503484A NZ 50348498 A NZ50348498 A NZ 50348498A NZ 503484 A NZ503484 A NZ 503484A
Authority
NZ
New Zealand
Prior art keywords
formula
benzothieno
alkyl
methylpiperazin
methyl
Prior art date
Application number
NZ503484A
Other languages
English (en)
Inventor
Hiroshi Tanaka
Toshiyuki Kohara
Kenji Hashimoto
Masatake Fujimura
Hideki Horiuchi
Hiroshi Yasumatsu
Koreichi Kimura
Koji Seio
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27322564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ503484(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of NZ503484A publication Critical patent/NZ503484A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ503484A 1997-09-02 1998-08-31 Optionally benzo fused thieno[2,3-b]benzoxazepine, thieno[2,3-b]benzodiazepine or thieno[2,3-b]benzothiaxazepine derivatives NZ503484A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP23670097 1997-09-02
JP27777197 1997-10-09
JP16572598 1998-06-12
PCT/JP1998/003915 WO1999011647A1 (en) 1997-09-02 1998-08-31 Fused thiophene compounds and medicinal use thereof

Publications (1)

Publication Number Publication Date
NZ503484A true NZ503484A (en) 2001-10-26

Family

ID=27322564

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ503484A NZ503484A (en) 1997-09-02 1998-08-31 Optionally benzo fused thieno[2,3-b]benzoxazepine, thieno[2,3-b]benzodiazepine or thieno[2,3-b]benzothiaxazepine derivatives

Country Status (16)

Country Link
US (2) US6271225B1 (cg-RX-API-DMAC10.html)
EP (1) EP1016664B1 (cg-RX-API-DMAC10.html)
JP (2) JP3156933B2 (cg-RX-API-DMAC10.html)
KR (1) KR20010021989A (cg-RX-API-DMAC10.html)
CN (1) CN1268949A (cg-RX-API-DMAC10.html)
AT (1) ATE244245T1 (cg-RX-API-DMAC10.html)
AU (1) AU739385B2 (cg-RX-API-DMAC10.html)
BR (1) BR9814042A (cg-RX-API-DMAC10.html)
CA (1) CA2302409A1 (cg-RX-API-DMAC10.html)
DE (1) DE69816102D1 (cg-RX-API-DMAC10.html)
HU (1) HUP0003718A3 (cg-RX-API-DMAC10.html)
IL (1) IL134812A0 (cg-RX-API-DMAC10.html)
NO (1) NO20001049L (cg-RX-API-DMAC10.html)
NZ (1) NZ503484A (cg-RX-API-DMAC10.html)
RU (1) RU2197491C2 (cg-RX-API-DMAC10.html)
WO (1) WO1999011647A1 (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US6751036B2 (en) * 2000-08-04 2004-06-15 Seagate Technology Llc Tuning track density for data storage device
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
EP2363396A1 (en) * 2001-06-11 2011-09-07 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
ES2285227T3 (es) 2002-08-05 2007-11-16 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina.
DE60332482D1 (de) 2002-12-10 2010-06-17 Virochem Pharma Inc Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
US20040236181A1 (en) * 2003-04-01 2004-11-25 Olympus Corporation In-body information acquiring apparatus and power-supply circuit
CA2536107A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
RU2248205C1 (ru) * 2003-09-18 2005-03-20 Открытое акционерное общество "Щелковский витаминный завод" Лекарственное средство в виде желатиновой капсулы
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
WO2005063771A1 (en) * 2003-12-22 2005-07-14 Teva Pharmaceutical Industries Ltd Methods of preparing olanzapine
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof
SG176488A1 (en) * 2006-11-15 2011-12-29 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections
PL395468A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
JP6551671B2 (ja) * 2015-08-11 2019-07-31 国立大学法人 熊本大学 アルツハイマー治療薬
US12365696B2 (en) 2019-05-10 2025-07-22 Dana-Farber Cancer Institute, Inc. Small-molecule focal adhesion kinase (FAK) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
CH468400A (de) 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3683084A (en) 1969-02-06 1972-08-08 Jean Schmutz Basically substituted heterocycles as anti-emetics
US3726977A (en) 1969-02-06 1973-04-10 Sandoz Ag 2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4115568A (en) 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
US4172831A (en) 1974-11-26 1979-10-30 Lilly Industries Limited Thieno-benzodiazepines
GB1533236A (en) * 1975-11-24 1978-11-22 Lilly Industries Ltd Thieno(1,5)benzodiazepine intermediates
US4157444A (en) 1978-03-13 1979-06-05 American Cyanamid Company 10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5538965A (en) 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
US5602121A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
US5700445A (en) 1994-12-12 1997-12-23 Allelix Biopharmaceuticals, Inc. N-methyl piperazine compounds having dopamine receptor affinity
US5602124A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5576314A (en) 1994-12-12 1996-11-19 Allelix Biopharmaceuticals Inc. Bicyclic nonane and decane compounds having dopamine receptor affinity
US5602120A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Benzyl-substituted compounds having dopamine receptor affinity
US5561127A (en) 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands

Also Published As

Publication number Publication date
US6271225B1 (en) 2001-08-07
DE69816102D1 (de) 2003-08-07
ATE244245T1 (de) 2003-07-15
IL134812A0 (en) 2001-04-30
NO20001049L (no) 2000-04-03
HUP0003718A3 (en) 2002-11-28
NO20001049D0 (no) 2000-03-01
JP3156933B2 (ja) 2001-04-16
KR20010021989A (ko) 2001-03-15
EP1016664A1 (en) 2000-07-05
HUP0003718A2 (hu) 2001-09-28
AU739385B2 (en) 2001-10-11
US20020042411A1 (en) 2002-04-11
EP1016664B1 (en) 2003-07-02
CN1268949A (zh) 2000-10-04
CA2302409A1 (en) 1999-03-11
WO1999011647A1 (en) 1999-03-11
RU2197491C2 (ru) 2003-01-27
JP2001072684A (ja) 2001-03-21
AU8889098A (en) 1999-03-22
US6455521B1 (en) 2002-09-24
EP1016664A4 (en) 2001-01-24
BR9814042A (pt) 2000-10-03
JP4354106B2 (ja) 2009-10-28

Similar Documents

Publication Publication Date Title
US6271225B1 (en) Fused thiophene compounds and medicinal use thereof
AU2005315914B2 (en) Bi- and tricyclic substituted phenyl methanones as glycine transporter I (GlyT-1) inhibitors for the treatment of Alzheimer's disease
JPWO1999011647A1 (ja) 縮合チオフェン化合物およびその医薬用途
US20050171101A1 (en) Phenanthridinones as parp inhibitors
US20070010537A1 (en) Fused pyramidine derivative and use thereof
JPH09291034A (ja) 縮合ピリジン化合物およびその医薬としての用途
US20100190772A1 (en) Substituted Azepine Derivatives As Serotonin Receptor Modulators
SI9400091A (en) Substituted pyrrolo(2,3-b)pyridine derivatives
CZ194994A3 (en) Piperazine and piperidine derivatives, process of their preparation and pharmaceutical compositions containing thereof
CS9101168A2 (en) Pharmaceutical mixtures and method of their active substance production
EP0409435A1 (en) Heteroaryl piperazine antipsychotic agents
CN101679272B (zh) 作为腺苷a3受体配体的三唑并[1,5-a]喹啉类
Hussenether et al. Clozapine derived 2, 3-dihydro-1H-1, 4-and 1, 5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing
WO1997003986A1 (en) Fused triazole compounds
CS236753B2 (en) Processing of thieno (1,5) benzodiazepine derivatives
AU2013394970B2 (en) Pyrroloquinoline derivatives as 5-HT6 antagonists, preparation method and use thereof
US4172831A (en) Thieno-benzodiazepines
JP2001515892A (ja) ベンゾキサジン−及びベンゾチアジン−誘導体、ならびにそれらの医薬への応用
NZ540768A (en) Benzamide derivatives as oxytocin agonists and vasopressin antagonists
KR20010022658A (ko) 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-d]피리미딘 유도체, 그의 제법 및 5ht길항제로서의 용도
HK1029340A (en) Fused thiophene compounds and medicinal use thereof
JP2005097276A (ja) 縮合ピリミジン誘導体およびその用途
KR0145181B1 (ko) 신규 벤조 [1,8] 나프티리딘 유도체 및 그의 제법
MXPA00002221A (en) Fused thiophene compounds and medicinal use thereof
CZ2000757A3 (cs) Kondenzované thiofenové sloučeniny a jejich farmaceutické použití

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)